Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds
(By Arthur Allen for KFF Health News) On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant
Read More(By Arthur Allen for KFF Health News) On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant
Read More(By Bob Herman for STAT) For many patients, one of the most antagonizing parts of a hospital visit is paying
Read More